Categories: News

Thermo Fisher Scientific Launches Novel Flow Cytometer with Imaging Capability

CARLSBAD, Calif., June 7, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Invitrogen Attune CytPix Flow Cytometer, an imaging-enhanced flow cytometer that combines acoustic focusing flow cytometry technology with a high-speed camera. The Attune CytPix allows users to collect high-performance fluorescent flow cytometry data from cells while simultaneously capturing high resolution brightfield images, allowing users to match images with their flow cytometry data to better understand the morphology and quality of the cells.

The Invitrogen Attune CytPix Flow Cytometer is a user-friendly, modular benchtop instrument that enables researchers working in QA/QC or cell therapy applications to gather additional information about their cells and the sample quality while running flow cytometry experiments without sacrificing speed or simplicity.

“Previously, gathering cell images and high-performance flow cytometry data required two separate experiments, split samples and additional time correlating cell phenotypes with images,” said Valerie Bressler-Hill, vice president and general manager, Protein and Cell Analysis, Thermo Fisher Scientific. “The Attune CytPix combines these workflows to offer imaging enhanced flow cytometry. It represents a step forward in what customers should expect from their benchtop flow cytometers by providing additional sample and data quality control in a simple, easy to use format.”

To learn more about the Invitrogen Attune CytPix Flow Cytometer, please visit www.thermofisher.com/cytpix.html.

* For Research Use Only.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com

Media Contact Information:

Mauricio Minotta
Phone: 760-805-5266
Email:mauricio.minotta@thermofisher.com

Olivia Hayum
Phone: 978-201-9131
Email: ohayum@greenough.biz

View original content:http://www.prnewswire.com/news-releases/thermo-fisher-scientific-launches-novel-flow-cytometer-with-imaging-capability-301306590.html

SOURCE Thermo Fisher Scientific

Staff

Recent Posts

Attune to Support Poppy Health’s $39M ARPA-H BREATHE Project in the U.S. Schools

VIENNA, Va., Dec. 19, 2025 /PRNewswire/ -- Attune announced today that the company will play…

2 hours ago

Feel30 Launches Austin-Based Telehealth Platform for Evidence-Proven TRT & Integrated At-Home Phlebotomy Services

AUSTIN, Texas, Dec. 19, 2025 /PRNewswire/ -- Feel30 , a telehealth platform specializing in testosterone…

2 hours ago

LISA LING JOINS TENDERCARE AS CHIEF CAREGIVER ADVOCATE & ADVISOR

– Will help address the difficult realities sandwich generation caregivers face with family caregiving –NEW…

2 hours ago

TENDERCARE LAUNCHING NATIONAL FAMILY CAREGIVING INFRASTRUCTURE, PARTNERING WITH THE AGING LIFE CARE ASSOCIATION® AND SUPPORTING THE CMS GUIDE MODEL PROGRAM

tendercare partnering with ALCA to raise national caregiving and eldercare industry standards;Selected as CMS GUIDE…

2 hours ago

HCAP Partners Announces Investment in Puzzle Healthcare

Investment to accelerate the growth of a post-acute care platform focused on reducing hospital readmissions…

2 hours ago

The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute

IRVING, Texas, Dec. 19, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation…

2 hours ago